Home › NDC Lookup › RxCUI directory › RxCUI 2273520

50 ML rituximab-pvvr 10 MG/ML Injection — RxCUI 2273520

RxNorm drug concept · Semantic clinical drug
RxCUI 2273520 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2273520
Official name50 ML rituximab-pvvr 10 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asrituximab-pvvr 500 MG per 50 ML Injection; riTUXimab-pvvr 500 MG in 50 ML Injection
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)11,167 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Rituximab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, absolutely — and it's one of the most important parts of your treatment. Rituximab can cause serious reactions during or shortly after the infusion, and these are most likely...
  • Why am I being watched so closely during my infusion — is that normal?
  • It's really important that you mention this to your doctor before starting rituximab, if you haven't already. Rituximab can cause the hepatitis B virus to 'wake up' again — a proce...
  • I had hepatitis B years ago — is that a problem?
📖 Read our full Rituximab Injection guide →

🕸️ Concept Web — How 50 ML rituximab-pvvr 10 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 50 ML rituximab-pvvr 10 MG/ML Injection RxCUI 2273520

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Rituximab 121191
    • Rituximab-pvvr 2273510
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ruxience 2273513
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Rituximab Injection 1657861
    • Rituximab-pvvr Injection 2647172
    • Rituximab Injectable Product 1157967
    • Rituximab-pvvr Injectable Product 2663424
    • Rituximab Injection [Ruxience] 2273515
    • Rituximab-pvvr Injection [Ruxience] 2654837
    • Ruxience Injectable Product 2273516
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Rituximab-pvvr 10 MG/ML SCDC · 2273511
  • Rituximab Injection SCDF · 1657861
  • Rituximab-pvvr Injection SCDFP · 2647172
  • Rituximab Injectable Product SCDG · 1157967
  • Rituximab-pvvr Injectable Product SCDGP · 2663424

Brand-Name Concepts

  • 50 ML rituximab-pvvr 10 MG/ML Injection [Ruxience] SBD · 2273521
  • Rituximab-pvvr 10 MG/ML [Ruxience] SBDC · 2273514
  • Rituximab Injection [Ruxience] SBDF · 2273515
  • Rituximab-pvvr Injection [Ruxience] SBDFP · 2654837
  • Ruxience Injectable Product SBDG · 2273516
  • Ruxience BN · 2273513

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2273520 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00069-0238-01 1 VIAL, SINGLE-USE in 1 CARTON (0069-0238-01) / 10 mL in 1... Ruxience Pfizer Laboratories Div Pfizer Inc 2020-01-23
00069-0249-01 1 VIAL, SINGLE-USE in 1 CARTON (0069-0249-01) / 50 mL in 1... Ruxience Pfizer Laboratories Div Pfizer Inc 2020-01-23
Observed labelers: Pfizer Laboratories Div Pfizer Inc (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
Q5119 Inj ruxience, 10 mg 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.